Home/Filings/4/0001209191-23-016719
4//SEC Filing

Shani Eli 4

Accession 0001209191-23-016719

CIK 0000818686other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:13 PM ET

Size

17.9 KB

Accession

0001209191-23-016719

Insider Transaction Report

Form 4
Period: 2023-03-03
Shani Eli
EVP,Global Marketing&Portfolio
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-03-04+3,17328,225 total
  • Exercise/Conversion

    Ordinary Shares

    2023-03-04+20,10748,332 total
  • Exercise/Conversion

    Ordinary Shares

    2023-03-05+5,89654,228 total
  • Award

    Restricted Share Units

    2023-03-03+59,76059,760 total
    Ordinary Shares (59,760 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2023-03-043,1730 total
    Ordinary Shares (3,173 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2023-03-0420,10760,321 total
    Ordinary Shares (20,107 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2023-03-055,89611,794 total
    Ordinary Shares (5,896 underlying)
Footnotes (6)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on March 3, 2023, with 14,940 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027.
  • [F4]Restricted share units were granted on March 4, 2019, with 3,173 vested on each of March 4, 2021, March 4, 2022, and March 4, 2023.
  • [F5]Restricted share units were granted on March 4, 2022, with 20,107 vested on March 4, 2023, and 20,107 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026.
  • [F6]Restricted share units were granted on March 5, 2021, with 5,896 vested on each of March 5, 2022 and March 5, 2023, 5,896 vesting on March 5, 2024, and 5,898 vesting on March 5, 2025.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001876642

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:13 PM ET
Size
17.9 KB